MENU
+Compare
ADVM
Stock ticker: NASDAQ
AS OF
Jan 31, 04:59 PM (EDT)
Price
$4.21
Change
-$0.20 (-4.54%)
Capitalization
87.79M

ADVM Adverum Biotechnologies Forecast, Technical & Fundamental Analysis

a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases

Industry Biotechnology
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADVM with price predictions
Jan 29, 2025

ADVM's RSI Indicator recovers from oversold territory

The RSI Oscillator for ADVM moved out of oversold territory on January 15, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 44 similar instances when the indicator left oversold territory. In of the 44 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 27, 2025. You may want to consider a long position or call options on ADVM as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADVM advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADVM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where ADVM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADVM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADVM entered a downward trend on January 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.609) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). ADVM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (71.942) is also within normal values, averaging (276.027).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADVM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADVM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Cardinal Way
Phone
+1 650 659-9323
Employees
121
Web
https://www.adverum.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IZM1.230.02
+1.65%
ICZOOM Group
UE20.560.22
+1.08%
Urban Edge Properties
WEGZY9.340.10
+1.08%
Weg SA
SMPNY14.000.08
+0.57%
Sompo Hldgs Inc
LAW5.15-0.02
-0.39%
CS Disco

ADVM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with IMNM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
+1.15%
IMNM - ADVM
43%
Loosely correlated
+12.41%
CDTX - ADVM
38%
Loosely correlated
+1.40%
TENX - ADVM
37%
Loosely correlated
-1.64%
VNDA - ADVM
33%
Poorly correlated
+1.10%
KPTI - ADVM
29%
Poorly correlated
+0.56%
More